相似文献
1
Secondary prevention of gastric cancer.
Gut. 2007 Dec;56(12):1646-7. doi: 10.1136/gut.2007.133926.
2
3
How to Manage a Patient With Gastric Intestinal Metaplasia: An International Perspective.
Gastroenterology. 2020 May;158(6):1534-1537. doi: 10.1053/j.gastro.2020.01.008. Epub 2020 Jan 9.
4
[Precancerous conditions and lesions of the stomach].
Klin Onkol. 2013;26 Suppl:S22-8. doi: 10.14735/amko2013s22.
5
[Precancerous conditions in gastric cancer (II): relationship between atrophic gastritis-intestinal metaplasia-gastric dysplasia-gastric carcinoma].
Rev Esp Enferm Dig. 1991 Jul;80(1):17-21.
6
Finding the needle in the haystack: identifying the high-risk "premalignant" gastric lesion.
Gastrointest Endosc. 2008 Jun;67(7):1019-20. doi: 10.1016/j.gie.2008.01.010.
7
Intestinal metaplasia surveillance: searching for the road-map.
World J Gastroenterol. 2013 Mar 14;19(10):1523-6. doi: 10.3748/wjg.v19.i10.1523.
8
Current Perspectives in Atrophic Gastritis.
Curr Gastroenterol Rep. 2020 Jun 15;22(8):38. doi: 10.1007/s11894-020-00775-1.
9
There is no clinical evidence of consequences after methylene blue chromoendoscopy.
Gastrointest Endosc. 2008 Jun;67(7):1209. doi: 10.1016/j.gie.2007.12.043.
10
[Reproducibility of histopathologic diagnosis of precursor lesions of gastric carcinoma in three Latin American countries].
Salud Publica Mex. 2010 Sep-Oct;52(5):386-90. doi: 10.1590/s0036-36342010000500005.
引用本文的文献
1
Assessment of Gastritis and Gastric Cancer Risk in the Chilean Population Using the OLGA System.
Pathol Oncol Res. 2019 Jul;25(3):1135-1142. doi: 10.1007/s12253-018-0532-3. Epub 2018 Nov 22.
2
Chronicles of a cancer foretold: 35 years of gastric cancer risk assessment.
Gut. 2016 May;65(5):721-5. doi: 10.1136/gutjnl-2015-310846. Epub 2016 Feb 29.
3
Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study.
Int J Cancer. 2015 Jan 15;136(2):425-34. doi: 10.1002/ijc.29005. Epub 2014 Jun 19.
本文引用的文献
1
Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands.
Gut. 2007 Dec;56(12):1665-70. doi: 10.1136/gut.2007.127167. Epub 2007 Aug 14.
2
Indefinite for non-invasive neoplasia lesions in gastric intestinal metaplasia: the immunophenotype.
J Clin Pathol. 2007 Jun;60(6):615-21. doi: 10.1136/jcp.2006.040386.
3
Usefulness of serum pepsinogens in Helicobacter pylori chronic gastritis: relationship with inflammation, activity, and density of the bacterium.
Dig Dis Sci. 2006 Oct;51(10):1791-5. doi: 10.1007/s10620-006-9206-1.
4
Gastritis staging in clinical practice: the OLGA staging system.
Gut. 2007 May;56(5):631-6. doi: 10.1136/gut.2006.106666. Epub 2006 Dec 1.
5
Assessing risks for gastric cancer: new tools for pathologists.
World J Gastroenterol. 2006 Sep 21;12(35):5622-7. doi: 10.3748/wjg.v12.i35.5622.
6
Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori.
J Clin Pathol. 2006 Dec;59(12):1293-9. doi: 10.1136/jcp.2005.036111. Epub 2006 Apr 27.
7
Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America.
Clin Gastroenterol Hepatol. 2006 Mar;4(3):306-14. doi: 10.1016/j.cgh.2005.11.003.
8
Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy.
Aliment Pharmacol Ther. 2005 Dec;22(11-12):1139-46. doi: 10.1111/j.1365-2036.2005.02734.x.
9
Staging gastritis: an international proposal.
Gastroenterology. 2005 Nov;129(5):1807-8. doi: 10.1053/j.gastro.2005.09.056.
10
Invasive and non-invasive diagnosis of Helicobacter pylori-associated atrophic gastritis: a comparative study.
Scand J Gastroenterol. 2005 Mar;40(3):297-301. doi: 10.1080/00365520410010607.
Zotero 插件